Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Prolyl hydroxylase EGLN3 |
---|
Ligand | BDBM50507428 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1829981 (CHEMBL4329855) |
---|
IC50 | 13±n/a nM |
---|
Citation | Liu, P; Wang, L; DuBois, BG; Colandrea, VJ; Liu, R; Cai, J; Du, X; Quan, W; Morris, W; Bai, J; Bishwokarma, B; Cheng, M; Piesvaux, J; Ray, K; Alpert, C; Chiu, CS; Zielstorff, M; Metzger, JM; Yang, L; Leung, D; Alleyne, C; Vincent, SH; Pucci, V; Li, X; Crespo, A; Stickens, D; Hale, JJ; Ujjainwalla, F; Sinz, CJ Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of Anemia. ACS Med Chem Lett9:1193-1198 (2018) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Prolyl hydroxylase EGLN3 |
---|
Name: | Prolyl hydroxylase EGLN3 |
Synonyms: | EGLN3 | EGLN3_HUMAN | Egl nine homolog 3 (EGLIN3) | Egl nine homolog 3 (EGLN3) |
Type: | Protein |
Mol. Mass.: | 27265.54 |
Organism: | Homo sapiens (Human) |
Description: | Q9H6Z9 |
Residue: | 239 |
Sequence: | MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQ
LAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKA
MVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEP
IFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED
|
|
|
BDBM50507428 |
---|
n/a |
---|
Name | BDBM50507428 |
Synonyms: | CHEMBL4567141 |
Type | Small organic molecule |
Emp. Form. | C16H13F3N4O6 |
Mol. Mass. | 414.2928 |
SMILES | OC(=O)CNC(=O)c1c(O)c2COCc2n(Cc2cnc(cn2)C(F)(F)F)c1=O |
Structure |
|